Journal article
TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models
The Journal of experimental medicine, Vol.212(3), pp.287-295
03/09/2015
DOI: 10.1084/jem.20142322
PMCID: PMC4354365
PMID: 25732305
Abstract
Variants in triggering receptor expressed on myeloid cells 2 (TREM2) confer high risk for Alzheimer's disease (AD) and other neurodegenerative diseases. However, the cell types and mechanisms underlying TREM2's involvement in neurodegeneration remain to be established. Here, we report that TREM2 is up-regulated on myeloid cells surrounding amyloid deposits in AD mouse models and human AD tissue. TREM2 was detected on CD45(hi)Ly6C(+) myeloid cells, but not on P2RY12(+) parenchymal microglia. In AD mice deficient for TREM2, the CD45(hi)Ly6C(+) macrophages are virtually eliminated, resulting in reduced inflammation and ameliorated amyloid and tau pathologies. These data suggest a functionally important role for TREM2(+) macrophages in AD pathogenesis and an unexpected, detrimental role of TREM2 in AD pathology. These findings have direct implications for future development of TREM2-targeted therapeutics.
Details
- Title: Subtitle
- TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models
- Creators
- Taylor R Jay - Case Western Reserve UniversityCrystal M Miller - Cleveland ClinicPaul J Cheng - Case Western Reserve UniversityLeah C Graham - Jackson LaboratoryShane Bemiller - Cleveland ClinicMargaret L Broihier - Case Western Reserve UniversityGuixiang Xu - Cleveland ClinicDaniel Margevicius - Cleveland ClinicJ Colleen Karlo - Case Western Reserve UniversityGregory L Sousa - Jackson LaboratoryAnne C Cotleur - Cleveland ClinicOleg Butovsky - Brigham and Women's HospitalLynn Bekris - Cleveland ClinicSusan M Staugaitis - Cleveland ClinicJames B Leverenz - Cleveland ClinicSanjay W Pimplikar - Case Western Reserve UniversityGary E Landreth - Case Western Reserve UniversityGareth R Howell - Jackson LaboratoryRichard M Ransohoff - Cleveland ClinicBruce T Lamb - Case Western Reserve University
- Resource Type
- Journal article
- Publication Details
- The Journal of experimental medicine, Vol.212(3), pp.287-295
- DOI
- 10.1084/jem.20142322
- PMID
- 25732305
- PMCID
- PMC4354365
- NLM abbreviation
- J Exp Med
- ISSN
- 0022-1007
- eISSN
- 1540-9538
- Grant note
- T32 NS067431 / NINDS NIH HHS T32 GM007250 / NIGMS NIH HHS UL1 TR000439 / NCATS NIH HHS AG023012 / NIA NIH HHS R01 AG023012 / NIA NIH HHS NS047804 / NINDS NIH HHS R01 NS088137 / NINDS NIH HHS NS087298 / NINDS NIH HHS F31 AG048704 / NIA NIH HHS
- Language
- English
- Date published
- 03/09/2015
- Academic Unit
- Iowa Neuroscience Institute; Neuroscience and Pharmacology
- Record Identifier
- 9985113008002771
Metrics
4 Record Views